13th Edition of International Conference on Neurology and Brain Disorders
October 19-21, 2026
Molecular Neuroscience and Neurodegeneration
Molecular Neuroscience:
Molecular neuroscience is a branch which monitors concepts in molecular biology integrated to the nervous systems of animals. The scope of the topic includes subjects like mechanisms of molecular signaling in the nervous system, molecular neuroanatomy, the effects of genetics and epigenetics on neuronal development, and the molecular basis for neuroplasticity and neurodegenerative diseases. As with molecular biology, molecular neuroscience is a relatively new field that is considerably dynamic.
- Behavioral epigenetics
- Behavioral genetics
- Cellular neuroscience
- Computational neuroscience
- Connectomics
- Imaging genetics
- Integrative neuroscience
Neurodegeneration:
Neurodegeneration is the gradual loss of structure or function of neurons, including their death. Many neurodegenerative diseases includes amyotrophic lateral sclerosis, multiple sclerosis, Parkinson's disease, Alzheimer's disease, Huntington's disease, and prion diseases occur as a result of neurodegenerative processes. Such diseases are incurable, resulting in progressive degeneration of neurons.
- Alzheimer's disease
- Amyotrophic lateral sclerosis
- Friedreich's ataxia
- Huntington's disease
- Lewy body disease
- Parkinson's disease
- Spinal muscular atrophy
Ken Ware
NeuroPhysics Therapy Institute and Research Centre, Australia
Yong Xiao Wang
Albany Medical College, United States
Joe Sam Robinson
Mercer University, United States
Daniel Curry
Texas Children’s Hospital, United States
Steven Benvenisti
Davis, Saperstein Salomon, PC, United States
Andrzej Stanislaw Cieplak
Independent researcher, United States
Younok Dumortier Shin
OnusBio, United StatesSubmit your abstract Today
Title : Atypical presentation of Juvenile myoclonic epilepsy in a 16-year-old female: A case report
George Diaz, Memorial Healthcare Systems, United States
Title : Triple-network dysfunction, ME/CFS, and the NeuroPhysics Treatment Process “A dynamical systems perspective on psychophysical organization and environmental interaction”
Ken Ware, NeuroPhysics Therapy Institute and Research Centre, Australia
Title : Beyond plaques: 10-nanometer-scale pathoconnectomics of Alzheimer’s disease
Ons M Saad, Panluminate Inc., United States
Title : Results from the global phase 3 trial (IB1001-303) evaluating levacetylleucine in children and adults with ataxia-telangiectasia
Chidinma Ejim, IntraBio, United States
Title : A phase 3, multinational, randomized, placebo-controlled, double-blind, crossover trial (IB1001-304) evaluating levacetylleucine in CACNA1A
Chidinma Ejim, IntraBio, United States
Title : Clinical and molecular phenotype of PTRHD1-associated juvenile parkinsonism
Bhavan A Modi, Barrow Neurological Institute at Phoenix Children's, United States